How Long Does Leprosy Last, Treated or Untreated?

Leprosy can last anywhere from a few years to a lifetime, depending on when it’s diagnosed and treated. With modern antibiotics, the active infection is curable in 6 to 12 months. But the full timeline of the disease, from the moment bacteria enter the body to the point a person is fully treated, often spans many years because of an unusually long incubation period.

Incubation: Years Before Symptoms Appear

The bacterium that causes leprosy, also known as Hansen’s disease, reproduces more slowly than almost any other human pathogen. The average incubation period is about five years, but symptoms can take as long as 20 years to show up. In some cases, they appear within a year. This means a person can carry the infection for a decade or more without knowing it, which is one reason leprosy is still difficult to eliminate globally.

Early symptoms are subtle: a patch of skin that’s lighter or redder than surrounding areas, sometimes with reduced sensation. Because these changes develop so gradually, many people don’t seek medical attention right away, adding more time to the overall duration of the disease before treatment begins.

Treatment Takes 6 to 12 Months

Once diagnosed, leprosy is treated with a combination of three antibiotics. The WHO recommends the same three-drug regimen for all patients, with the duration depending on how widespread the infection is. People with fewer skin lesions and a lower bacterial load (called paucibacillary leprosy) take the regimen for 6 months. Those with more extensive disease (multibacillary leprosy) take it for 12 months.

Treatment is highly effective. Within the first few doses, the bacterial count drops dramatically and the person is generally no longer contagious. Completing the full course is critical, though, because stopping early increases the risk of relapse.

Relapse Risk After Treatment

Relapse after completing treatment is uncommon but possible. In a large WHO study tracking over 20,000 patients with multibacillary leprosy, only 67 relapsed over an eight-year observation period. The average time to relapse was about 3.4 years after finishing treatment, and 75% of relapses occurred within 6 years.

For those with the milder paucibacillary form, relapse tends to happen sooner. Among more than 51,000 tracked patients, half of relapses occurred within two and a half years, and 75% within five years. This is why follow-up monitoring after treatment matters, even though the overall relapse rate is low.

Immune Reactions Can Extend the Timeline

Most people with leprosy experience at least one immune reaction during the course of their disease. These aren’t side effects of the medication. They’re the body’s inflammatory response to bacterial proteins in the skin and nerves, and they can flare up before treatment starts, during treatment, or even after it’s finished.

These reactions can cause sudden pain, swelling, and nerve inflammation. They’re a major concern because they can trigger new nerve damage even in someone who has already been cured of the infection itself. Managing reactions sometimes requires months of anti-inflammatory treatment, which effectively extends the period of active medical care well beyond the 6 or 12 months of antibiotics.

Nerve Damage Can Be Permanent

This is the part of the timeline that matters most for long-term quality of life. While the infection itself is curable, the nerve damage it causes is not always reversible. Leprosy targets peripheral nerves, particularly in the hands, feet, and face, destroying sensation and sometimes motor function.

Research shows that after treatment reduces inflammation, nerves do attempt to regenerate. Regenerating nerve fibers have been found persisting for decades in treated patients. However, this regrowth is often blocked by scar tissue that replaces the most distal nerve endings, the ones closest to the skin surface. The result is that protective sensation in the hands and feet may never fully return, even though the underlying infection is gone.

In clinical studies, about 78% of patients showed improved or restored nerve function after treatment with anti-inflammatory steroids. That’s an encouraging number, but it also means roughly one in five patients did not recover nerve function, and the degree of improvement varied. Nerve damage that existed for a long time before treatment began is the hardest to reverse.

Untreated Leprosy Can Last a Lifetime

Without treatment, leprosy is a chronic, progressive disease. It does not resolve on its own. Over years and decades, ongoing nerve damage leads to loss of sensation, muscle weakness, and the injuries and infections that follow from not being able to feel pain. The visible deformities historically associated with leprosy are the result of years of untreated disease, not an inevitable feature of the infection.

The distinction between the infection and its consequences is key to understanding how long leprosy “lasts.” The bacterial infection can be eliminated in under a year. But the disability it leaves behind, particularly in people diagnosed late, can persist for the rest of a person’s life and requires ongoing care including wound prevention, physical therapy, and sometimes surgery.